Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Indian Official Sees Agreement With Japan On Trade In Indian Generics

This article was originally published in PharmAsia News

Executive Summary

An Indian trade negotiator says he sees signs Japan is relaxing its resistance to generic drugs from India, the source of some past friction. An Indian government official who has participated in four years of talks with Japanese counterparts said he expects an agreement soon between the two countries. He said he noticed the first signs of a positive response by Japanese officials who had been resisting inclusion of India's generic drugs in a bilateral trade agreement. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts